Update: Temple Health and Keystone First Family Health Plans have reached a new contract agreement. 

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

view all Clinical Trials

Overview

The objective of this clinical study is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma.

Clinical Trial Information

Protocol

TIRB# 31113

Phase

3

Condition(s)

Asthma

Investigator

Kartik Shenoy, MD

Coordinator

Arwa Mukhtar, Dave Miller, Sheril George

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma